The cardiac rhythm management (CRM) devices market is poised to grow by USD 3.73 billion during 2020-2024, progressing at a CAGR of almost 5% during the forecast period.
The report on the cardiac rhythm management (CRM) devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the rising incidence of CVDs.
The cardiac rhythm management (CRM) devices market analysis includes Product, End-user, and Geography landscape. This study identifies the technological advances as one of the prime reasons driving cardiac rhythm management (CRM) devices market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The cardiac rhythm management (CRM) devices market covers the following areas:
- Cardiac Rhythm Management (CRM) Devices Market Sizing
- Cardiac Rhythm Management (CRM) Devices Market Forecast
- Cardiac Rhythm Management (CRM) Devices Market Analysis
Companies Mentioned
- Abbott Laboratories
- BIOTRONIK SE & Co. KG
- Boston Scientific Corp.
- Cook Medical LLC
- General Electric Co.
- Hill-Rom Holdings Inc.
- Medtronic Plc
- MicroPort Scientific Corp.
- SCHILLER AG
- Stryker Corp
Source: BusinesssWire
0 Comments